Céline Bellanger
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 4
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Catherine Pellat‐Deceunynck (16 shared papers)Martine Amiot (9 shared papers)Benoît Tessoulin (13 shared papers)David Chiron (13 shared papers)Philippe Moreau (10 shared papers)Cyrille Touzeau (9 shared papers)Patricia Gomez‐Bougie (6 shared papers)Steven Le Gouill (8 shared papers)
- Journals
- Blood (7 papers)Leukemia (3 papers)Frontiers in Oncology (2 papers)Haematologica (2 papers)Cancers (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Céline Bellanger
18 papers receiving 315 citations
Peers
Comparison fields: 5 of 49
- Genetics 88
- Hematology 70
- Pathology and Forensic Medicine 110
- Oncology 120
- Immunology 86
Countries citing papers authored by Céline Bellanger
This map shows the geographic impact of Céline Bellanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Bellanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Bellanger more than expected).
Fields of papers citing papers by Céline Bellanger
This network shows the impact of papers produced by Céline Bellanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Bellanger. The network helps show where Céline Bellanger may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Bellanger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 68 | |
| 2 | 2019 | 56 | |
| 3 | 2019 | 53 | |
| 4 | 2020 | 34 | |
| 5 | 2019 | 26 | |
| 6 | 2018 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2022 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 4 | |
| 12 | 2016 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2026 | 0 |
About Céline Bellanger
Céline Bellanger is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Immunology and Hematology, having authored 21 papers that have together received 318 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers), HIV/AIDS drug development and treatment (3 papers) and Logic, programming, and type systems (2 papers). The work is most often cited by research in Genetics (88 citations), Hematology (70 citations), Pathology and Forensic Medicine (110 citations), Oncology (120 citations) and Immunology (86 citations). Céline Bellanger has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Catherine Pellat‐Deceunynck, Martine Amiot, Benoît Tessoulin, David Chiron, Philippe Moreau, Cyrille Touzeau, Patricia Gomez‐Bougie, Steven Le Gouill, Sophie Maïga and Yannick Le Bris. Their work appears in journals such as Blood, Leukemia, Frontiers in Oncology, Haematologica and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.